BDBM182103 US9676728, 7-D (-)-2-(Amino(2-methoxy-4,6-dimethylphenyl)methyl)-1H-benzo[d]imidazole-5-carbonitrile

SMILES COc1cc(C)cc(C)c1C(N)c1nc2cc(ccc2[nH]1)C#N

InChI Key InChIKey=JDESVNBQIVCCKU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 182103   

TargetComplement factor B(Human)
Novartis

US Patent
LigandPNGBDBM182103(US9676728, 7-D (-)-2-(Amino(2-methoxy-4,6-dimethyl...)
Affinity DataIC50: 8.70E+3nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
Go to US Patent